Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Top Cited Papers
- 31 December 2005
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 49 (7), 1053-1066
- https://doi.org/10.1016/j.neuropharm.2005.06.004
Abstract
No abstract availableFunding Information
- FRAXA Research Foundation
This publication has 52 references indexed in Scilit:
- A phenotypic and molecular characterization of the fmr1‐tm1Cgr Fragile X mouseGenes, Brain and Behavior, 2004
- The mGluR theory of fragile X mental retardationTrends in Neurosciences, 2004
- The Fragile X Syndrome Protein FMRP Associates with BC1 RNA and Regulates the Translation of Specific mRNAs at SynapsesCell, 2003
- Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X SyndromeEpilepsia, 2000
- Epilepsy and EEG Findings in Males with Fragile X SyndromeEpilepsia, 1999
- A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiationNature, 1994
- An in vivo electrophysiological study of the ontogeny of excitatory and inhibitory processes in the rat hippocampusDevelopmental Brain Research, 1989
- Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the ratPharmacology Biochemistry and Behavior, 1986
- Experience with prenatal fragile X detectionAmerican Journal of Medical Genetics, 1984
- The open-field test: A critical review.Psychological Bulletin, 1976